Mansukh Mandaviya pli scheme

In a significant stride towards self-sufficiency in pharmaceutical production, India has successfully commenced the manufacturing of 38 active pharmaceutical ingredients (APIs) that were previously imported. Union Health Minister, Mansukh Mandaviya, announced this achievement during the inaugural of Healthcare Summit hosted by the Indian Institute of Management Ahmedabad (IIM-A). The accomplishment was made possible through the implementation of the production-linked incentive (PLI) initiative within the pharmaceutical sector.

The impetus for this self-reliant strategy emerged after the 2017 border conflict with China in Doklam, prompting India to reassess its heavy reliance on a single source for 95% of APIs used in the formulation industry.

Through the PLI scheme, the Indian government aimed to reduce dependence on foreign sources for 54 APIs and promote domestic production for the formulation industry. This move has eliminated the need for importing these APIs, bolstering India’s position as an Atmanirbhar Bharat (self-reliant India). The government allocated a substantial budget of ₹15,000 crore for the pharmaceutical sector under the PLI scheme, demonstrating its commitment to fostering self-reliance.

The Union Health Minister also highlighted the government’s core objective of enhancing healthcare accessibility and affordability in rural areas. To address the shortage of medical professionals, the government expanded medical education by increasing the number of MBBS seats from 52,000 to 1,07,000 over the past nine years. Furthermore, the establishment of 54 new medical colleges reflects a dedicated effort to bridge the healthcare gap in the country.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related News